
The global respiratory care devices market is projected to grow at an annual rate of about 8% from 2026 to 2034, reaching a market size of $47.5 billion. This growth is driven by the rising prevalence of chronic respiratory diseases like COPD, asthma, and sleep apnea, increased demand for home healthcare, and ongoing technological innovations such as AI-enabled ventilators and smart inhalers. North America currently leads the market with 41% share, supported by high disease prevalence and advanced healthcare infrastructure. The market is expected to benefit further from post-COVID-19 awareness and government investments in healthcare facilities.